Ask a litigation question, get an answer ASAP!
Thousands of highly rated, verified litigation lawyers.
Click here to chat with a lawyer about your rights.

   Sec. 571. IC 35-48-4-14.7(k) (Concerning a pharmacy or NPLEx retailer that discloses information concerning the sale of a product containing ephedrine or pseudoephedrine).

As added by P.L.105-2022, SEC.12.